Name: InMed Pharmaceuticals Inc. (INM) Balance Sheet
Creator: FinSpry

InMed Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for InMed Pharmaceuticals Inc. (INM) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Current Assets
Cash and Cash Equivalents	11.08	6.61	8.91	6.22	7.41
Short-Term Investments	0.00	0.04	0.04	0.04	0.05
Cash & Short-Term Investments	11.08	6.61	8.96	6.22	7.41
Accounts Receivable	0.47	0.35	0.26	0.09	0.01
Inventory	0.96	1.24	1.62	2.49	0.00
Other Current Assets	0.37	0.48	0.50	0.80	0.84
Total Current Assets	12.87	8.69	11.33	9.60	8.38
Non-Current Assets
Property, Plant & Equipment (Net)	0.99	1.25	0.72	0.90	0.33
Intangible Assets	1.62	1.78	1.95	2.11	1.06
Other Non-Current Assets	0.10	0.10	0.10	0.18	0.01
Total Non-Current Assets	2.71	3.13	2.77	3.19	1.40
Total Assets	15.58	11.82	14.11	12.79	9.78
Current Liabilities
Accounts Payable	0.37	1.65	0.54	2.92	1.25
Short-Term Debt	0.44	0.00	0.00	0.00	0.00
Accrued Liabilities	0.54	0.99	1.06	1.11	1.36
Other Current Liabilities	1.03	0.04	0.02	0.50	0.00
Total Current Liabilities	1.84	1.97	2.00	3.32	2.22
Non-Current Liabilities
Long-Term Debt	0.31	0.64	0.02	0.39	0.19
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.31	0.64	0.02	0.39	0.19
Total Liabilities	2.15	2.62	2.02	3.71	2.40
Stockholders' Equity
Common Stock	91.22	82.78	77.62	70.72	60.59
Retained Earnings	-117.24	-109.08	-101.40	-93.45	-74.85
Accumulated Other Comprehensive Income	0.13	82.91	0.13	0.13	0.13
Additional Paid-in Capital	39.32	35.37	35.74	31.68	21.51
Shares Outstanding	2.00	0.45	0.17	0.03	0.00
Total Stockholders' Equity	13.43	9.21	12.09	9.08	7.38
Total Liabilities & Equity	15.58	11.82	14.11	12.79	9.78